These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32861496)

  • 1. Longitudinal effects of enrofloxacin or tulathromycin use in preweaned calves at high risk of bovine respiratory disease on the shedding of antimicrobial-resistant fecal Escherichia coli.
    Pereira RV; Altier C; Siler JD; Mann S; Jordan D; Warnick LD
    J Dairy Sci; 2020 Nov; 103(11):10547-10559. PubMed ID: 32861496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
    Crosby S; Credille B; Giguère S; Berghaus R
    J Anim Sci; 2018 Apr; 96(4):1259-1267. PubMed ID: 29471391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin.
    Pereira RV; Foditsch C; Siler JD; Dulièpre SC; Altier C; Garzon A; Warnick LD
    Sci Rep; 2020 Nov; 10(1):19327. PubMed ID: 33168881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of on-farm use of antimicrobial drugs on resistance in fecal Escherichia coli of preweaned dairy calves.
    Pereira RV; Siler JD; Ng JC; Davis MA; Grohn YT; Warnick LD
    J Dairy Sci; 2014 Dec; 97(12):7644-54. PubMed ID: 25306279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tulathromycin or enrofloxacin for initial treatment of naturally occurring bovine respiratory disease in feeder calves.
    Robb EJ; Tucker CM; Corley L; Bryson WL; Rogers KC; Sturgess K; Bade DJ; Brodersen B
    Vet Ther; 2007; 8(2):127-35. PubMed ID: 17616947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the comparative clinical and economic consequences of tulathromycin for treatment of present or anticipated outbreaks of bovine respiratory disease in feedlot cattle in the United States.
    Nautrup BP; Van Vlaenderen I; Gasper SM; Holland RE
    J Anim Sci; 2013 Dec; 91(12):5868-77. PubMed ID: 24126273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of enrofloxacin and tulathromycin for treatment of preweaning respiratory disease in dairy heifers.
    Heins BD; Nydam DV; Woolums AR; Berghaus RD; Overton MW
    J Dairy Sci; 2014; 97(1):372-82. PubMed ID: 24183689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.
    Sarchet JJ; Pollreisz JP; Bechtol DT; Blanding MR; Saltman RL; Taube PC
    PLoS One; 2022; 17(2):e0247213. PubMed ID: 35143504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness of tulathromycin, a novel triamilide antimicrobial, for the control of respiratory disease in cattle at high risk for developing bovine respiratory disease.
    Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL
    Vet Ther; 2005; 6(2):136-42. PubMed ID: 16094561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of respiratory disease and a preventative antibiotic treatment on growth, survival, age at first calving, and milk production of dairy heifers.
    Stanton AL; Kelton DF; LeBlanc SJ; Wormuth J; Leslie KE
    J Dairy Sci; 2012 Sep; 95(9):4950-4960. PubMed ID: 22916899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial use policy change in pre-weaned dairy calves and its impact on antimicrobial resistance in commensal Escherichia coli: a cross sectional and ecological study.
    Afema JA; Davis MA; Sischo WM
    BMC Microbiol; 2019 Sep; 19(1):217. PubMed ID: 31514734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of treatment with long-acting antibiotic at postweaning movement on respiratory disease and on growth in commercial dairy calves.
    Stanton AL; Kelton DF; Leblanc SJ; Millman ST; Wormuth J; Dingwell RT; Leslie KE
    J Dairy Sci; 2010 Feb; 93(2):574-81. PubMed ID: 20105529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of treatment with enrofloxacin or tulathromycin on fecal microbiota composition and genetic function of dairy calves.
    Foditsch C; Pereira RVV; Siler JD; Altier C; Warnick LD
    PLoS One; 2019; 14(12):e0219635. PubMed ID: 31825967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeding of waste milk to Holstein calves affects antimicrobial resistance of Escherichia coli and Pasteurella multocida isolated from fecal and nasal swabs.
    Maynou G; Bach A; Terré M
    J Dairy Sci; 2017 Apr; 100(4):2682-2694. PubMed ID: 28215892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves.
    Godinho KS; Rae A; Windsor GD; Tilt N; Rowan TG; Sunderland SJ
    Vet Ther; 2005; 6(2):96-112. PubMed ID: 16094558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for antimicrobial resistance in fecal Escherichia coli from preweaned dairy calves.
    Duse A; Waller KP; Emanuelson U; Unnerstad HE; Persson Y; Bengtsson B
    J Dairy Sci; 2015 Jan; 98(1):500-16. PubMed ID: 25465547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of florfenicol and tulathromycine for the treatment of undifferentiated fever in feedlot calves.
    Perrett T; Abutarbush SM; Wildman BK; Fuchs MT; Schunicht OC; Pollock CM; Fenton RK; Jim GK; Guichon PT; Booker CW; Berg J; Roder J; Spire M
    Vet Ther; 2008; 9(2):128-40. PubMed ID: 18597251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease.
    Rooney KA; Nutsch RG; Skogerboe TL; Weigel DJ; Gajewski K; Kilgore WR
    Vet Ther; 2005; 6(2):154-66. PubMed ID: 16094563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of tulathromycin, a novel triamilide antimicrobial, against bovine respiratory disease in feeder calves.
    Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL
    Vet Ther; 2005; 6(2):143-53. PubMed ID: 16094562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Tulathromycin Treatment for Bovine Respiratory Disease and Antimicrobial Resistance Profiles among Gut Commensals and Foodborne Bacterial Pathogens Isolated from Feces of Beef Steers.
    Lewy K; Cernicchiaro N; Dixon AL; Beyene TJ; Shane D; George LA; Nagaraja TG; White BJ; Sanderson MW
    J Food Prot; 2022 Aug; 85(8):1221-1231. PubMed ID: 35653626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.